VC and Investment
Biotechnology
As India's bioeconomy soars to a remarkable valuation of $151 billion, the government's Biotechnology Industry Research Assistance Council (BIRAC) has underscored the critical need for innovation and private sector investment to unlock further growth. 21 October 2024
Today's issue
Refine Search
Biotechnology
San Francisco, USA-based biotech start-up Kivu Bioscience has announced the closing of a $92 million Series A financing round led by Novo Holdings, which as of year-end 2011123 had total assets of 149 billion euros ($161 billion). 28 October 2024
Biotechnology
Ottimo Pharma, a biotech founded by Medicxi in 2020, has emerged from stealth mode with an executive team packed with prominent industry leaders. 28 October 2024
Biotechnology
Biostar Pharmaceuticals has announced its upcoming initial public offering (IPO) on the Hong Kong Stock Exchange, aiming to raise funds to advance its growing oncology pipeline and support its global expansion efforts. 25 October 2024
Biotechnology
Belgian biotech Agomab Therapeutics today announced a $89 million (82.1 million euros) Series D financing round, with participation from new investors Sanofi and Invus 25 October 2024
Pharmaceutical
Alpha-9 Oncology, a Canadian radiopharmaceutical company, has raised $175 million in an oversubscribed series C financing round led by Lightspeed Venture Partners and Ascenta Capital. 24 October 2024
Biotechnology
US clinical-stage biotech AvenCell Therapeutics announced that it has raised $112 million in Series B financing, which was led by global life sciences investor Novo Holdings. 23 October 2024
Biotechnology
Boston, USA-based Seaport Therapeutics has announced the closing of an oversubscribed $225 million Series B financing round, adding to the $100 million it pulled in along with its launch in April. 21 October 2024
Biotechnology
As India's bioeconomy soars to a remarkable valuation of $151 billion, the government's Biotechnology Industry Research Assistance Council (BIRAC) has underscored the critical need for innovation and private sector investment to unlock further growth. 21 October 2024
Biotechnology
LaNova Medicines, a Shanghai-based biopharma company, has announced that it has secured 3 billion yuan ($41 million) in its series C funding round. 18 October 2024
Biotechnology
California, USA-based biotech Terray Therapeutics, yesterday announced the closing of an oversubscribed Series B funding of $120 million. 18 October 2024
Pharmaceutical
Sanofi has entered into an agreement with Orano Med, a subsidiary of the Orano Group, to advance the development of radioligand therapies for rare cancers. 17 October 2024
Pharmaceutical
Netherlands-based life sciences venture capital firm Forbion has raised more than 2 billion euros ($2.2 billion) across its two newest funds. 16 October 2024
Pharmaceutical
The American Lung Association Research Institute has announced a $22 million research investment in 2024, marking one of the largest lung health research programs in the USA. 16 October 2024
Pharmaceutical
TenNor Therapeutics, a Suzhou-based clinical-stage biotech company, has announced the initial closing of a series E financing round, raising over 300 million yuan ($41 million). 16 October 2024
Biotechnology
In Cambridge, UK, the protein specialist Nuclera has raised $75 million in a funding round led by Elevage Medical Technologies and backed by Patient Square Capital. 16 October 2024
Biotechnology
Tolerance Bio has announced the closing of its oversubscribed $17.2 million seed financing round, led by Columbus Venture Partners. 16 October 2024
Biotechnology
In Hong Kong, Akeso Biopharma has successfully raised $250 million through a share placement, marking its second major fundraising effort of 2024. 15 October 2024
Pharmaceutical
French biopharma company Inventiva has announced financing of immediately 94.1 million euros ($103 million) and up to 348 million euros, subject to satisfaction of specified conditions. 15 October 2024
Biotechnology
Turnstone Biologics has announced a major restructuring of its operations, cutting its workforce by approximately 60%. 14 October 2024
Biotechnology
Boston, USA-based Upstream Bio, a biotech developing treatments for inflammatory diseases, with an initial focus on severe respiratory disorders, has made an impressive start to life as a public-listed company.00000 14 October 2024
Biotechnology
Bavarian Nordic is aiming to raise $86 million to develop cancer and respiratory virus drugs by floating on New York’s Nasdaq. 18 February 2016
Pharmaceutical
Shield Therapeutics has raised £32.5 million ($47 million) in a UK flotation ahead of its proposed admission to the Alternative Investment Market (AIM) branch of the London Stock Exchange (LSE). 12 February 2016
Pharmaceutical
In our weekly expert view piece, John Maloney, commerical product director at Bloomberg BNA and editors of Bloomberg Law: corporate transactions, examines the proposed Shire-Baxalta merger. 9 February 2016
Biotechnology
Oxis International has said following debt restructuring the company will be in sound financial shape to continue its Phase I/ II clinical trial of OXS-1550, a drug to treat non-Hodgkins lymphoma and leukemia. 2 February 2016
Pharmaceutical
Medicxi Ventures on Tuesday announced the close of Medicxi Ventures 1 (MV1), a new 210 million euro ($250 million) fund that will focus on early-stage life sciences investments. 2 February 2016
Pharmaceutical
In our weekly expert view piece, Joe Stelzer, managing partner at Cavendish Corporate Finance LLP, examines the emerging ‘research by acquisition’ model in big pharma. 2 February 2016
Biotechnology
Dutch biopharmaceutical company Kiadis Pharma has signed a deal with The Leukemia and Lymphoma Society (LLS) to further develop its lead product ATIR10, it has been announced. 1 February 2016
Pharmaceutical
Germany’s Merck on Wednesday announced two appointments to head its businesses in North America and China in a bid to strengthen its position in the regions. 27 January 2016
Biosimilars
Korean biopharmaceutical company Celltrion is to start using cloud-based technology to accelerate development of its biosimilars programs in rheumatoid arthritis, respiratory diseases and cancer. 22 January 2016
Biotechnology
Clinical-stage gene delivery company GenVec said there is no certainty the trials for its lead product CGF166 to treat hearing loss will continue. 21 January 2016
Pharmaceutical
US health care giant Johnson & Johnson has said it will cut about 3,000 jobs in its medical-devices unit in a bid to revive the struggling business. 20 January 2016
Pharmaceutical
Pharma giant Pfizer said it is pouring in a total of $46 million into four early-stage research companies in a bid to expand its R&D investments. 11 January 2016
Pharmaceutical
Switzerland-based Cardiorentis AG said it has raised 60 million Swiss Franc ($60 million) via private investors to advance its Phase III trials for Ularitide, a therapy for acute decompensated heart failure (ADHF), including upcoming regulatory submissions expected in the second half of 2016. 11 January 2016
Generics
Market capitalization of Indian drug makers has taken a hit as the US FDA rains warnings against manufacturing practices, The Pharma letter’s Anjali Shukla tracks the dent. 6 January 2016
Pharmaceutical
Shares in Valeant Pharmaceuticals dropped over 10% on December 28 after the company said chief executive Michael Pearson is taking a medical leave with immediate effect. 4 January 2016
Pharmaceutical
Returns on pharmaceutical research and development are too low for the industry to sustain future pipeline investment, according to a report by the Deloitte Centre for Health Solutions. 14 December 2015
Pharmaceutical
Chinese pharma company Huya Bioscience International said it has opened its first corporate office in Korea, in line with its strategy to accelerate drug development by aiding local firms initiate clinical trials and gain approval for new compounds. 3 December 2015
Pharmaceutical
German pharma giant Merck is considering selling its allergy business Allergopharma in a bid to reduce debts of more than 10 billion euros, according to reports. 30 November 2015
article
French pharma company Servier is to axe more than 600 employees and overhaul its sales network in France, it has been announced. 30 November 2015
Pharmaceutical
UK pharma major GlaxoSmithKline has cut 40% of its workforce in China as part of the measures to revamp its operations following the infamous bribery scandal. 30 November 2015
Company Spotlight
A US biotech company dedicated to creating oral drugs with an emphasis on indications in virology and immunology.
Sign up to receive email updates
Join industry leaders for a daily roundup of biotech & pharma news
Copyright © The Pharma Letter 2024 | Headless Content Management with Blaze